div class=trans-pagebutton class=gotoPage data-page=1Page 1button div class=trans-imagea href=https:reader042fdocumentpubreader042viewer20220411015ed8e6576714ca7f4768c76bhtml5page1jpg target=_blank img data-url=documentresume-n-el-rgimen-fem-fluoruracil-epidoxorubicina-mitomicina-fu-evaluadohtmlpage=1 data-page=1 class=trans-thumb lazyload alt=Page 1: repebisupcheduperepebisupchedupearticulosactacancerolv21n2a4pdf · RESUME N El Régimen FEM Fluoruracil - Epidoxorubicina - Mitomicina fué evaluado en 19 pacientes loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader042fdocumentpubreader042viewer20220411015ed8e6576714ca7f4768c76bhtml5thumbnails1jpg width=140 height=200 adivdivdiv class=trans-pagebutton class=gotoPage data-page=2Page 2button div class=trans-imagea href=https:reader042fdocumentpubreader042viewer20220411015ed8e6576714ca7f4768c76bhtml5page2jpg target=_blank img data-url=documentresume-n-el-rgimen-fem-fluoruracil-epidoxorubicina-mitomicina-fu-evaluadohtmlpage=2 data-page=2 class=trans-thumb lazyload alt=Page 2: repebisupcheduperepebisupchedupearticulosactacancerolv21n2a4pdf · RESUME N El Régimen FEM Fluoruracil - Epidoxorubicina - Mitomicina fué evaluado en 19 pacientes loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader042fdocumentpubreader042viewer20220411015ed8e6576714ca7f4768c76bhtml5thumbnails2jpg width=140 height=200 adivdivdiv class=trans-pagebutton class=gotoPage data-page=3Page 3button div class=trans-imagea href=https:reader042fdocumentpubreader042viewer20220411015ed8e6576714ca7f4768c76bhtml5page3jpg target=_blank img data-url=documentresume-n-el-rgimen-fem-fluoruracil-epidoxorubicina-mitomicina-fu-evaluadohtmlpage=3 data-page=3 class=trans-thumb lazyload alt=Page 3: repebisupcheduperepebisupchedupearticulosactacancerolv21n2a4pdf · RESUME N El...